{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Sedoxantrone_Trihydrochloride",
  "nciThesaurus": {
    "casRegistry": "119221-49-7",
    "chebiId": "",
    "chemicalFormula": "C21H27N5OS.3ClH",
    "definition": "The trihydrochloride salt of the anthrapyrazole antineoplastic antibiotic sedoxantrone with potential antineoplastic activity. Sedoxantrone intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.",
    "fdaUniiCode": "X9GSL37ED0",
    "identifier": "C1576",
    "preferredName": "Sedoxantrone Trihydrochloride",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C2107"
    ],
    "synonyms": [
      "2H-(1)Benzothiopyrano(4,3,2-cd)indazol-8-ol, 5-((2-aminoethyl)amino)-2-(2-(diethylamino)ethyl)-, Trihydrochloride",
      "CI 958",
      "CI-958",
      "LEDOXANTRONE TRIHYDROCHLORIDE",
      "Ledoxantrone Trihydrochloride",
      "Sedoxantrone Trihydrochloride",
      "sedoxantrone trihydrochloride"
    ]
  }
}